Trade Summary

3 days ago, Feider Stephen, serving as Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 6,676 shares at $12.61 per share, for a total transaction value of $84,165.00. Following this transaction, Feider Stephen now holds 166,053 shares of BBNX.

This sale represents a 3.87% decrease in Feider Stephen's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 6:00 PM ET, 1 day after the trade was made.

Beta Bionics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.